InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by NICOLS JOHN J, Chairman & CEO. Officer active across 2 companies, notably Codexis, INC.. In total, 8 disclosures have been logged. The latest transaction was disclosed on 11 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€84,96638,500 shares@ €2.20690.058% mcap12.4% of flow
Common Stock
SEC:0001567619-22-010516:0·
€81,95838,500 shares@ €2.12880.056% mcap12.0% of flow
Common Stock
SEC:0001567619-22-006782:0·
€104,43735,000 shares@ €2.983950.3% of flow
Common Stock
SEC:0001567619-21-020031·
€104,43735,000 shares@ €2.98390.071% mcap15.3% of flow
Common Stock
SEC:0001567619-21-020031:0·
€103,18435,000 shares@ €2.948149.7% of flow
Common Stock
SEC:0001567619-21-015831·
€103,18435,000 shares@ €2.94810.070% mcap15.1% of flow
Common Stock
SEC:0001567619-21-015831:0·
€100,71035,385 shares@ €2.8461100.0% of flow
Common Stock
SEC:0001567619-21-010722·
€100,71035,385 shares@ €2.84610.068% mcap14.7% of flow
Common Stock
SEC:0001567619-21-010722:0·
8 of 8 declarations
About NICOLS JOHN J
John J. Nicols is the President & CEO of Codexis, Inc. He is responsible for the strategic and operational leadership of the company, which focuses on biotechnology solutions. Nicols plays a key role in developing new initiatives to enhance the products and services offered by the company.
